Tat-CIRP TFA
Tat-CIRP is a peptide inhibitor that disrupts the MD-2/CIRP interaction, a key pathway in sterile inflammation. It has demonstrated efficacy in reducing cerebral infarct volume and improving functional outcomes in both rodent and non-human primate models of ischemic stroke, supporting its use in neuroinflammation and stroke research.
Product Specifications
Field of Research
Immunology & Inflammation
Molecular Weight
2997.30
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2372207 1.0 µg DNA
THUMPD3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details